TipRanks
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
US Market
XTLB
XTL Biopharmaceuticals Sponsored ADR
RESEARCH TOOLSreports
Want to see XTLB full AI Analyst Report?

XTL Biopharmaceuticals Sponsored ADR (XTLB) Stock News & Sentiment

147 Followers
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition
Premium
Company Announcements
XTL Biopharmaceuticals Faces Derivative Action Bid Over Failed Social Proxy Acquisition
2M ago
6K
XTLB
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period
Premium
Company Announcements
XTL Biopharmaceuticals Regains Nasdaq Compliance and Enters One-Year Monitoring Period
3M ago
6K
XTLB
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine
Premium
Company Announcements
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine
3M ago
6K
XTLB
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase
Premium
Company Announcements
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase
3M ago
6K
XTLB
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026
Premium
Company Announcements
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026
4M ago
6K
XTLB
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
Premium
Company Announcements
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
5M ago
6K
XTLB
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
Premium
Company Announcements
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
5M ago
6K
XTLB
More XTLB News >

XTLB News on the Web

XTL BioPharma Closes Acquisition Of Psyga Bio; Shifts Focus To Psychedelic Therapies
rttnews
Bullish
XTL Biopharmaceuticals Completes Psyga Bio Acquisition, Refocuses on Psychedelic Medicine
TipRanks News
Bearish
XTL Biopharmaceuticals Shareholders Approve Psyga Bio Acquisition and Major Capital Increase
TipRanks News
Neutral
XTL Biopharmaceuticals Adjourns Extraordinary Shareholder Meeting to June 29, 2026
TipRanks News
Bearish
XTL Biopharmaceuticals (XTLB) Faces Nasdaq Compliance Challenges Amid Stock Surge
GuruFocus News
Bearish
XTL Biopharmaceuticals Faces Added Nasdaq Delisting Risk Over Late 2025 Annual Report
TipRanks News
Bearish
XTL Biopharmaceuticals Calls June 22, 2026 Meeting to Approve Psyga Bio Acquisition and Capital Raise
TipRanks News
Neutral
XTL Biopharmaceuticals Wins Conditional Nasdaq Listing Reprieve Tied to Psyga Bio Deal
TipRanks News
Bearish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.75 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is XTLB’s Media Buzz Sentiment?
Currently, no data Available
What is XTLB’s weekly average amount of articles?
In an average week, 0.75 articles about XTLB are published.
    What is XTLB’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    CMXHFCSL
    RZLTRezolute
    AMGNAmgen
    PMCUFPro Medicus Limited
    ABTAbbott Laboratories
    Showing the stocks with the most bullish news sentiment over the past week